Search Results

There are 18923 results for: content related to: Outcome of pregnancy in women with inflammatory bowel disease treated with antitumor necrosis factor therapy

  1. You have free access to this content
    2016 ACR/ARHP Annual Meeting Abstract Supplement

    Arthritis & Rheumatology

    Volume 68, Issue S10, October 2016, Pages: 1–4550,

    Version of Record online : 8 NOV 2016, DOI: 10.1002/art.39977

  2. You have free access to this content
    ACR Meeting

    Arthritis & Rheumatism

    Volume 64, Issue S10, October 2012, Pages: S1–S1216,

    Version of Record online : 11 OCT 2012, DOI: 10.1002/art.37735

  3. You have free access to this content
    Antitumor necrosis factor treatment for pediatric inflammatory bowel disease

    Inflammatory Bowel Diseases

    Volume 18, Issue 5, May 2012, Pages: 985–1002, Charlotte I. de Bie, Johanna C. Escher and Lissy de Ridder

    Version of Record online : 20 SEP 2011, DOI: 10.1002/ibd.21871

  4. You have free access to this content
    2015 ACR/ARHP Annual Meeting Abstract Supplement

    Arthritis & Rheumatology

    Volume 67, Issue S10, October 2015, Pages: 1–4046,

    Version of Record online : 5 NOV 2015, DOI: 10.1002/art.39448

  5. Clinical implications of variations in anti-infliximab antibody levels in patients with inflammatory bowel disease

    Inflammatory Bowel Diseases

    Volume 18, Issue 12, December 2012, Pages: 2209–2217, Casper Steenholdt, Magid Al-khalaf, Jørn Brynskov, Klaus Bendtzen, Ole Ø. Thomsen and Mark A. Ainsworth

    Version of Record online : 16 FEB 2012, DOI: 10.1002/ibd.22910

  6. Systematic review: factors associated with relapse of inflammatory bowel disease after discontinuation of anti-TNF therapy

    Alimentary Pharmacology & Therapeutics

    Volume 42, Issue 4, August 2015, Pages: 391–405, J. P. Gisbert, A. C. Marín and M. Chaparro

    Version of Record online : 15 JUN 2015, DOI: 10.1111/apt.13276

  7. You have free access to this content
    Systematic review with meta-analysis: the efficacy of a second anti-TNF in patients with inflammatory bowel disease whose previous anti-TNF treatment has failed

    Alimentary Pharmacology & Therapeutics

    Volume 41, Issue 7, April 2015, Pages: 613–623, J. P. Gisbert, A. C. Marín, A. G. McNicholl and M. Chaparro

    Version of Record online : 4 FEB 2015, DOI: 10.1111/apt.13083

  8. Clinical utility of antihuman lambda chain-based enzyme-linked immunosorbent assay (ELISA) versus double antigen ELISA for the detection of anti-infliximab antibodies

    Inflammatory Bowel Diseases

    Volume 18, Issue 9, September 2012, Pages: 1628–1633, Uri Kopylov, Yoav Mazor, Miri Yavzori, Ella Fudim, Lior Katz, Daniel Coscas, Orit Picard, Yehuda Chowers, Rami Eliakim and Shomron Ben-Horin

    Version of Record online : 29 OCT 2011, DOI: 10.1002/ibd.21919

  9. You have free access to this content
    Review article: why, when and how to de-escalate therapy in inflammatory bowel diseases

    Alimentary Pharmacology & Therapeutics

    Volume 40, Issue 4, August 2014, Pages: 338–353, B. Pariente and D. Laharie

    Version of Record online : 23 JUN 2014, DOI: 10.1111/apt.12838

  10. Monitoring functional serum antitumor necrosis factor antibody level in Crohn's disease patients who maintained and those who lost response to anti-TNF

    Inflammatory Bowel Diseases

    Volume 16, Issue 11, November 2010, Pages: 1898–1904, Akihiro Yamada, Koji Sono, Nobuo Hosoe, Nobuo Takada and Yasuo Suzuki

    Version of Record online : 22 MAR 2010, DOI: 10.1002/ibd.21259

  11. A multicentre randomized trial of the treatment of patients with pemphigus vulgaris with infliximab and prednisone compared with prednisone alone

    British Journal of Dermatology

    Volume 172, Issue 3, March 2015, Pages: 760–768, R.P. Hall III, J. Fairley, D. Woodley, V.P. Werth, D. Hannah, R.D. Streilein, J. McKillip, J. Okawa, M. Rose, L.L. Keyes-Elstein, A. Pinckney, A. Overington, J. Wedgwood, L. Ding and B. Welch

    Version of Record online : 5 FEB 2015, DOI: 10.1111/bjd.13350

  12. Comparison of medical costs among patients using adalimumab and infliximab: A retrospective study (COMPAIRS)

    Inflammatory Bowel Diseases

    Volume 18, Issue 11, November 2012, Pages: 2043–2055, Daniel A. Sussman, Nisa Kubiliun, Parvez M. Mulani, Jingdong Chao, Carol A.T. Gillis, Mei Yang, Mei Lu and Maria T. Abreu

    Version of Record online : 12 JAN 2012, DOI: 10.1002/ibd.22873

  13. You have free access to this content
    High intra-uterine exposure to infliximab following maternal anti-TNF treatment during pregnancy

    Alimentary Pharmacology & Therapeutics

    Volume 33, Issue 9, May 2011, Pages: 1053–1058, Z. Zelinkova, C. de Haar, L. de Ridder, M. J. Pierik, E. J. Kuipers, M. P. Peppelenbosch and C. J. van der Woude

    Version of Record online : 1 MAR 2011, DOI: 10.1111/j.1365-2036.2011.04617.x

  14. You have free access to this content
    ABSTRACTS – Online Panel Discussion (i-Pos)

    International Journal of Rheumatic Diseases

    Volume 11, Issue s1, September 2008, Pages: A84–A514,

    Version of Record online : 31 AUG 2008, DOI: 10.1111/j.1479-8077.2008.00373.x

  15. You have free access to this content
    Adalimumab or infliximab as monotherapy, or in combination with an immunomodulator, in the treatment of Crohn's disease

    Alimentary Pharmacology & Therapeutics

    Volume 44, Issue 10, November 2016, Pages: 1102–1113, J. Cosnes, H. Sokol, A. Bourrier, I. Nion-Larmurier, A. Wisniewski, C. Landman, P. Marteau, L. Beaugerie, K. Perez and P. Seksik

    Version of Record online : 26 SEP 2016, DOI: 10.1111/apt.13808

  16. Scheduled infliximab monotherapy to prevent recurrence of Crohn's disease following ileocolic or ileal resection: A 3-year prospective randomized open trial

    Inflammatory Bowel Diseases

    Volume 18, Issue 9, September 2012, Pages: 1617–1623, Koji Yoshida, Ken Fukunaga, Hiroki Ikeuchi, Koji Kamikozuru, Nobuyuki Hida, Yoshio Ohda, Yoko Yokoyama, Masaki Iimuro, Naohisa Takeda, Kyoichi Kato, Risa Kikuyama, Kazuko Nagase, Kazutoshi Hori, Shiro Nakamura, Hiroto Miwa and Takayuki Matsumoto

    Version of Record online : 13 NOV 2011, DOI: 10.1002/ibd.21928

  17. You have free access to this content
    Detection of infliximab levels and anti-infliximab antibodies: a comparison of three different assays

    Alimentary Pharmacology & Therapeutics

    Volume 36, Issue 8, October 2012, Pages: 765–771, N. Vande Casteele, D. J. Buurman, M. G. G. Sturkenboom, J. H. Kleibeuker, S. Vermeire, T. Rispens, D. van der Kleij, A. Gils and G. Dijkstra

    Version of Record online : 28 AUG 2012, DOI: 10.1111/apt.12030

  18. You have free access to this content
    Infliximab improves inflammation and anthropometric measures in pediatric Crohn's disease

    Journal of Gastroenterology and Hepatology

    Volume 25, Issue 4, April 2010, Pages: 810–816, Daniel M Sinitsky, Daniel A Lemberg, Steven T Leach, Timothy D Bohane, Reuben Jackson and Andrew S Day

    Version of Record online : 24 NOV 2009, DOI: 10.1111/j.1440-1746.2009.06195.x

  19. You have free access to this content
    Pre-existing IgG antibodies cross-reacting with the Fab region of infliximab predict efficacy and safety of infliximab therapy in inflammatory bowel disease

    Alimentary Pharmacology & Therapeutics

    Volume 37, Issue 12, June 2013, Pages: 1172–1183, C. Steenholdt, Y. Palarasah, K. Bendtzen, A. Teisner, J. Brynskov, B. Teisner and C. H. Nielsen

    Version of Record online : 7 MAY 2013, DOI: 10.1111/apt.12330

  20. Long-term outcome of treatment with infliximab in pediatric-onset Crohn's disease: A population-based study

    Inflammatory Bowel Diseases

    Volume 17, Issue 10, October 2011, Pages: 2144–2152, Valérie Crombé, Julia Salleron, Guillaume Savoye, Jean-Louis Dupas, Gwénola Vernier-Massouille, Eric Lerebours, Antoine Cortot, Véronique Merle, Francis Vasseur, Dominique Turck, Corinne Gower-Rousseau, Marc Lémann, Jean-Frédéric Colombel and Alain Duhamel

    Version of Record online : 1 FEB 2011, DOI: 10.1002/ibd.21615